Nitroxoline

Nitroxoline

CAT N°: 28391
Price:

From 48.00 40.80

Nitroxoline is an 8-hydroxyquinoline that has diverse biological activities, including antibacterial, antiproliferative, and bromodomain interaction-inhibiting properties.{45442,45443,45444,45445} Nitroxoline is active against the bacteria E. coli, S. aureus, E. faecalis, K. pneumoniae, and P. mirabilis in vitro (MIC90s = 4, 4, 8, 8, and 8 mg/L, respectively).{45442} It also inhibits biofilm formation of certain strains of multidrug-resistant (MDR) A. baumannii and P. aeruginosa, as well as methicillin-resistant S. aureus (MRSA) and S. epidermidis (MRSE) with minimum biofilm eradication concentration (MBEC) values of 46.9, 1,500, 188, and 125 ?M, respectively.{45443} Nitroxoline inhibits the growth of human U87 and U251 glioma, A549 lung, and PC3 prostate cancer cells (IC50s = 50, 6, 38, and 23 ?g/ml, respectively).{45444} In vivo, it reduces tumor growth in a PTEN- and KRAS-driven glioma mouse model when administered at a dose of 80 mg/kg per day. Nitroxoline also inhibits the interaction between the first bromodomain of bromodomain-containing protein 4 (BRD4) with acetylated histone H4 with an IC50 value of 0.98 ?M.{45445}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 5-nitro-8-quinolinol
  • Correlated keywords
    • 52440-95-6 64667-01-2 Nitroxine 5NOK NOK A82 A 82 BAS 58 BAS58 Nibiol Nitroxolin Noxibiol NSC 74947 NSC74947 NSC74948 74948 oxychinoline oxyquinoline 5-Nitrox 5Nitrox 8hydroxyquinoline anti-bacterial anti-proliferative Escherichia Staphylococcus Enterococcus Klebsiella Proteus Acinetobacter Pseudomonas U-87 U-251 A-549 PC-3 H-4 BRD-4
  • Product Overview:
    Nitroxoline is an 8-hydroxyquinoline that has diverse biological activities, including antibacterial, antiproliferative, and bromodomain interaction-inhibiting properties.{45442,45443,45444,45445} Nitroxoline is active against the bacteria E. coli, S. aureus, E. faecalis, K. pneumoniae, and P. mirabilis in vitro (MIC90s = 4, 4, 8, 8, and 8 mg/L, respectively).{45442} It also inhibits biofilm formation of certain strains of multidrug-resistant (MDR) A. baumannii and P. aeruginosa, as well as methicillin-resistant S. aureus (MRSA) and S. epidermidis (MRSE) with minimum biofilm eradication concentration (MBEC) values of 46.9, 1,500, 188, and 125 ?M, respectively.{45443} Nitroxoline inhibits the growth of human U87 and U251 glioma, A549 lung, and PC3 prostate cancer cells (IC50s = 50, 6, 38, and 23 ?g/ml, respectively).{45444} In vivo, it reduces tumor growth in a PTEN- and KRAS-driven glioma mouse model when administered at a dose of 80 mg/kg per day. Nitroxoline also inhibits the interaction between the first bromodomain of bromodomain-containing protein 4 (BRD4) with acetylated histone H4 with an IC50 value of 0.98 ?M.{45445}

We also advise you